Published in Prog Neuropsychopharmacol Biol Psychiatry on February 08, 2007
Pharmacokinetic-pharmacodynamic modeling of the D₂ and 5-HT (2A) receptor occupancy of risperidone and paliperidone in rats. Pharm Res (2012) 0.92
Comparative Pharmacology of Risperidone and Paliperidone. Drugs R D (2015) 0.84
Involvement of cytochrome P450 3A4 and P-glycoprotein in first-pass intestinal extraction of omeprazole in rabbits. Acta Pharmacol Sin (2009) 0.78
Use of In Vitro and Predictive In Silico Models to Study the Inhibition of Cytochrome P4503A by Stilbenes. PLoS One (2015) 0.78
Inhibition of cytochrome P450 3A by acetoxylated analogues of resveratrol in in vitro and in silico models. Sci Rep (2016) 0.75
BRCA1 expression serves a role in vincristine resistance in colon cancer cells. Oncol Lett (2017) 0.75
Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity. Diabetes (2011) 1.73
Pharmacodynamics of unfractionated heparin during and after a hemodialysis session. Am J Kidney Dis (2008) 1.64
Vancomycin: a review of population pharmacokinetic analyses. Clin Pharmacokinet (2012) 1.53
Dobutamine-induced myoclonia in severe renal failure. Nephrol Dial Transplant (2004) 1.43
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014. MMWR Morb Mortal Wkly Rep (2014) 1.42
Unexpected overestimation of methotrexate plasma concentrations: analysis of a single center pediatric population. Ther Drug Monit (2014) 1.38
Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment. J Biol Chem (2002) 1.28
Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. J Lipid Res (2004) 1.26
Population pharmacokinetics of atazanavir in human immunodeficiency virus-infected patients. Ther Drug Monit (2008) 1.09
Niemann-Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestine. Biochem Biophys Res Commun (2006) 1.09
Apolipoprotein A-II, HDL metabolism and atherosclerosis. Atherosclerosis (2002) 1.06
Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology. Neurobiol Dis (2011) 1.00
Impact of multiaccess infusion devices on in vitro drug delivery during multi-infusion therapy. Anesth Analg (2009) 1.00
Minimal effect of MDR1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of indinavir in HIV-infected patients. Br J Clin Pharmacol (2007) 0.98
Rexinoid bexarotene modulates triglyceride but not cholesterol metabolism via gene-specific permissivity of the RXR/LXR heterodimer in the liver. Arterioscler Thromb Vasc Biol (2009) 0.96
Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal. Br J Clin Pharmacol (2011) 0.95
Pharmacokinetics of the low molecular weight heparin enoxaparin during 48 h after bolus administration as an anticoagulant in haemodialysis. Nephrol Dial Transplant (2003) 0.95
Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and (1)H NMR spectroscopy. J Chromatogr A (2008) 0.94
Differences between eccentric and rotary tablet machines in the evaluation of powder densification behaviour. Int J Pharm (2005) 0.94
Population pharmacokinetic analysis during the first 2 years of life: an overview. Clin Pharmacokinet (2012) 0.93
The RXR agonist bexarotene improves cholesterol homeostasis and inhibits atherosclerosis progression in a mouse model of mixed dyslipidemia. Arterioscler Thromb Vasc Biol (2006) 0.92
Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends. Curr Pharm Des (2015) 0.92
Nanoemulsion formulation of fisetin improves bioavailability and antitumour activity in mice. Int J Pharm (2012) 0.91
Defective VLDL metabolism and severe atherosclerosis in mice expressing human apolipoprotein E isoforms but lacking the LDL receptor. Biochim Biophys Acta (2004) 0.90
Intestine-specific regulation of PPARalpha gene transcription by liver X receptors. Endocrinology (2008) 0.89
Improvement of cefpodoxime proxetil oral absorption in rats by an oil-in-water submicron emulsion. Int J Pharm (2003) 0.88
Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin Neuropharmacol (2002) 0.88
Self-intoxication with baclofen in alcohol-dependent patients with co-existing psychiatric illness: an emergency department case series. Alcohol Alcohol (2013) 0.87
Regulation of the scavenger receptor BI and the LDL receptor by activators of aldosterone production, angiotensin II and PMA, in the human NCI-H295R adrenocortical cell line. Biochim Biophys Acta (2003) 0.87
[Avascular osteonecrosis of the jaws induced by diphosphonates]. Therapie (2006) 0.87
Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysis. Pain (2009) 0.86
Infusion set characteristics such as antireflux valve and dead-space volume affect drug delivery: an experimental study designed to enhance infusion sets. Anesth Analg (2010) 0.85
The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Arch Physiol Biochem (2012) 0.85
Anti-Plasmodium properties of group IA, IB, IIA and III secreted phospholipases A2 are serum-dependent. Toxicon (2004) 0.84
Biological rhythms: a neglected factor of variability in pharmacokinetic studies. J Pharm Sci (2008) 0.84
Assessment of implementation of a standardized parenteral formulation for early nutritional support of very preterm infants. Eur J Pediatr (2006) 0.84
Impact of plasma and intracellular exposure and CYP3A4, CYP3A5, and ABCB1 genetic polymorphisms on vincristine-induced neurotoxicity. Cancer Chemother Pharmacol (2011) 0.84
PPARβ/δ activation induces enteroendocrine L cell GLP-1 production. Gastroenterology (2011) 0.83
Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages. Arterioscler Thromb Vasc Biol (2008) 0.83
Which improvements could prevent the departure of the left-without-being-seen patients? Emerg Med J (2010) 0.83
Daily melatonin supplementation in mice increases atherosclerosis in proximal aorta. Biochem Biophys Res Commun (2002) 0.82
Aseptic simulation test challenged with microorganisms for validation of pharmacy operators. Am J Health Syst Pharm (2012) 0.82
Analytical and semipreparative enantioseparation of 9-hydroxyrisperidone, the main metabolite of risperidone, using high-performance liquid chromatography and capillary electrophoresis. Validation and determination of enantiomeric purity. J Chromatogr A (2007) 0.81
Population pharmacokinetics and pharmacogenetics of vincristine in paediatric patients treated for solid tumour diseases. Cancer Chemother Pharmacol (2010) 0.81
Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators. Ann Occup Hyg (2012) 0.81
Activation of intestinal peroxisome proliferator-activated receptor-α increases high-density lipoprotein production. Eur Heart J (2012) 0.80
A new tetrahydrated form of sodium naproxen. J Pharm Sci (2007) 0.80
Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins. J Biol Chem (2002) 0.80
Performance of target-controlled sufentanil infusion in obese patients. Anesthesiology (2003) 0.80
Population Pharmacokinetics of High-Dose Oxazepam in Alcohol-Dependent Patients: Is There a Risk of Accumulation? Ther Drug Monit (2016) 0.80
The impact on drug mass flow rate of interrupting and resuming carrier fluid flow: an in vitro study on a very low dead-space volume infusion set. Anesth Analg (2011) 0.79
Impact of physical incompatibility on drug mass flow rates: example of furosemide-midazolam incompatibility. Ann Intensive Care (2012) 0.79
In vitro comparison of two changeover methods for vasoactive drug infusion pumps: quick-change versus automated relay. Biomed Tech (Berl) (2015) 0.79
Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study. Chronobiol Int (2010) 0.79
The impact of multilumen infusion devices on the occurrence of known physical drug incompatibility: a controlled in vitro study. Anesth Analg (2012) 0.78
Effect of oil-in-water submicron emulsion surface charge on oral absorption of a poorly water-soluble drug in rats. Drug Deliv (2008) 0.78
Sigma-1 ligands: Tic-hydantoin as a key pharmacophore. Eur J Med Chem (2009) 0.78
Quantitative analysis of drugs in biological matrices by HPLC hyphenated to fluorescence detection. Bioanalysis (2015) 0.78
Effect of genetic polymorphisms in UDP-glucuronosyltransferase 1A6 (UGT1A6) on acetylsalicylic acid metabolism in healthy female volunteers. Pharmacology (2009) 0.78
Cluster analysis: an alternative method for covariate selection in population pharmacokinetic modeling. J Pharmacokinet Pharmacodyn (2005) 0.78
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization. Ther Drug Monit (2016) 0.78
Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0. Fundam Clin Pharmacol (2006) 0.77
SR-BI does not require raft/caveola localisation for cholesteryl ester selective uptake in the human adrenal cell line NCI-H295R. Biochim Biophys Acta (2003) 0.77
Effects of a seven-day continuous infusion of ropivacaine on circadian rhythms in the rat. Chronobiol Int (2006) 0.77
EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate. Inorg Chem (2006) 0.77
Early-glycation of apolipoprotein E: effect on its binding to LDL receptor, scavenger receptor A and heparan sulfates. Biochim Biophys Acta (2002) 0.77
Poly-cyclodextrin functionalized porous bioceramics for local chemotherapy and anticancer bone reconstruction. J Biomed Mater Res B Appl Biomater (2013) 0.77
Chronopharmacokinetics of imipenem in the rat. Chronobiol Int (2007) 0.77
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans. Clin Pharmacol Ther (2006) 0.76